文献速递胸部肿瘤

胸膜间皮瘤多组学与单细胞分析揭示新型未定态分子表型与不良预后相关

Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype.
PubMed 文献 · J Thorac Oncol · 2025-11-28

该研究对40例胸膜间皮瘤患者的93份样本进行单细胞RNA测序、 bulk外显子与RNA测序、光学基因组作图、空间转录组及组织学分析,识别出一种富集于双相型间皮瘤的新型未定态恶性细胞状态,并验证MEST(未定态)和MSLN(上皮样)两个预后免疫组化标志物。

要点

  • 新型未定态恶性细胞状态富集于双相型胸膜间皮瘤。
  • TGF-β和GAS6-AXL信号为候选恶性细胞状态驱动通路。
  • MEST(未定态)和MSLN(上皮样)为预后免疫组化标志物。

核心结论

  • 多组学与单细胞分析识别出胸膜间皮瘤新型未定态恶性细胞状态,与不良预后相关,并提供候选驱动通路和预后标志物。

研究设计与样本

  • 研究纳入40例胸膜间皮瘤患者的93份样本,采用单细胞RNA测序、bulk外显子与RNA测序、光学基因组作图、空间转录组及组织学分析。

主要发现

  • 在双相型胸膜间皮瘤中富集一种新型未定态恶性细胞状态。
  • 基于推断的拷贝数变异,三种恶性细胞状态均可见于单个克隆,提示状态不受克隆限制。
  • TGF-β和GAS6-AXL信号被识别为候选恶性细胞状态驱动通路。
  • 验证MEST(未定态)和MSLN(上皮样)两个预后免疫组化标志物。

临床怎么用

  • MEST和MSLN免疫组化或可用于胸膜间皮瘤患者分层。
  • TGF-β和GAS6-AXL信号通路需进一步实验探索与临床验证。

局限性

  • 研究基于40例患者样本,结论需进一步实验探索和临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Multiomics pleural mesothelioma (PM) studies have identified prognostic molecular subsets of PM histologic types, epithelioid (ePM), biphasic (bPM), and sarcomatoid (sPM), defined by relative tumor cell content. However, the underlying biology modulating survival remains unknown. METHODS: Using 93 samples from 40 patients, we performed single-cell RNA sequencing (scRNA-seq), bulk exome and RNA sequencing, optical genome mapping, spatial transcriptomics, and histologic analyses to identify candidate drivers and prognostic biomarkers of malignant cell (MC) state. RESULTS: We identified a novel uncommitted MC state enriched in bPM tumors. Using inferred copy number variants, we observed all three MC states within individual clones suggesting MC state is not clonally restricted. We identified TGF-β and GAS6-AXL signaling as candidate MC state drivers for further study. Finally, we validated two prognostic MC state immunohistochemistry biomarkers, MEST (uncommitted) and MSLN (epithelioid). CONCLUSIONS: These multiomic, scRNA-seq analyses of primary patient tissues provide new candidate drivers of MC state and novel biomarkers to improve patient stratification. Further experimental exploration and clinical validation of these findings may reveal new treatment strategies and refine current clinical decision-making in PM.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Severson DT, Freyaldenhoven S, Wadowski B, et al. Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype. J Thorac Oncol. 2025. PMID: 41319863. doi:10.1016/j.jtho.2025.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。